henry oral semaglutide Meds Review: GLP-1 Telehealth Provider Analysis – PlexusDx Henry Meds Review - Is

Classification and coding system of the American Hospital Formulary Service

In the OASIS-2 trial, participants in East Asia with type 2 diabetes achieved 14.3% weight loss with 50 mg daily oral semaglutide compared to 1.3% with placebo

Funding This study has been supported by the Spanish Ministry of Science and Innovation (PI15/00283, PI18/00805, PI19/00394, PI18/01001, CPII19/00009) integrated into the Plan Nacional de I+D+I and co-financed by the Instituto de Salud Carlos III (ISCIII)-Subdireccin General de Evaluacin and the Fondo Europeo de Desarrollo Regional (FEDER)

doi: 10.1001/jamapsychiatry.2014.2637

Scientific References Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial

PFGA12 ameliorates Hypoxic-Ischemic brain injury by directly regulating PRDX1 and inhibiting ferroptosis